Assignee
ADOC SSF LLC
US·4 granted patents·8 pending applications·0 citations·filing 2020–2025
Top patents by PatentIndex Score
12 records- 0180US2025250587A1Primary cell gene editingADOC SSF LLC·Filed 2025·Application pending·0 cites
- 0272US12276656B2Compositions and methods for identification of antigen specific T cellsADOC SSF LLC·Filed 2022·Granted Apr 15, 2025·0 cites·16 claims
- 0372US12247061B2Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapyADOC SSF LLC·Filed 2022·Granted Mar 11, 2025·0 cites·11 claims
- 0467US2025171519A1Peptide-mhc compactsADOC SSF LLC·Filed 2025·Application pending·0 cites
- 0566US12240885B2Peptide-MHC compactsADOC SSF LLC·Filed 2020·Granted Mar 4, 2025·0 cites·17 claims
- 0665US2026001931A1Compositions and methods for the treatment of cancer using a cd8 engineered t cell therapyADOC SSF LLC·Filed 2025·Application pending·0 cites
- 0764US2025244313A1Compositions and methods for identification of antigen specific t cellsADOC SSF LLC·Filed 2025·Application pending·0 cites
- 0861US2024229128A1Methods for improved t cell receptor sequencingADOC SSF LLC·Filed 2023·Application pending·0 cites
- 0959US2024133886A1Methods of assessing cell productsADOC SSF LLC·Filed 2023·Application pending·0 cites
- 1055US2024100096A1Methods of activating t cellsADOC SSF LLC·Filed 2023·Application pending·0 cites
- 1153US12359247B2Methods of performing GUIDE-Seq on primary human T cellsADOC SSF LLC·Filed 2020·Granted Jul 15, 2025·0 cites·17 claims
- 1252US2024271121A1Compositions and methods for isolating t cell receptors (tcrs) and cells expressing the sameADOC SSF LLC·Filed 2024·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →